Kathy Giusti

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Kathy Giusti (born 1958) is the founder of the Multiple Myeloma Research Foundation, and a member of its board of directors.[1] She is the Henry & Allison McCance Family Senior Fellow at Harvard Business School, where she serves as Faculty Co-Chair of HBS Kraft Precision Medicine Accelerator,[2] she is recognized as a pioneer of precision medicine, a champion of open-access data sharing, and a strong advocate for patient engagement in their treatment and care and as part of the research process.[3]

Giusti founded the MMRF in 1998, shortly after being diagnosed with the incurable blood cancer multiple myeloma.[4] Since then, she has led the foundation in establishing collaborative research models in the areas of tissue banking, genomics, and clinical trials;[5] these models have helped accelerate the pace at which treatments are brought to patients—treatments that have nearly tripled patients' survival.[6]

In 2016, Giusti was named Co-Chair of the HBS Kraft Precision Medicine Accelerator, a $20M endowed program provided by Robert Kraft and the Kraft Family Foundation; the mission of HBS Kraft Accelerator is to drive innovation to speed breakthroughs in precision medicine for all cancers.[7]

Giusti has received several awards for her leadership. Most recently, she was recognized as one of 34 leaders changing healthcare by Fortune magazine,[8] she was also ranked #19 on Fortune's list of Worlds' 50 Greatest Leaders[9] and was named one of Time magazine’s 100 Most Influential People in the world.[10] She was named an Open Science Champion of Change by the White House,[3] and was appointed to and served on President Obama’s Precision Medicine Initiative Working Group.[11]

Giusti has more than two decades of experience in the pharmaceutical industry, she received her MBA from Harvard Business School and holds an honorary doctorate from the University of Vermont.[12]


External links[edit]